Aptar Group has acquired a pair of pharmaceutical services company to help broaden is portfolio of services that support pharma and biotech customers.
With the $50 million acquisition of Nanopharma and Gateway Analytical, Aptar Group said it can help its customers “accelerate and derisk their complex product developments”.
The expanded services platform will enable Aptar Pharma to collaborate earlier with customers to support their complex drug formulations and delivery requirements as they face increasingly competitive and regulated markets.
Located in Newport, UK, Nanopharm is a science-driven provider of orally inhaled and nasal drug product design and development services.
Gateway Analytical, located in Gibsonia, PA, provides industry-leading particulate detection and predictive analytical services to customers developing injectable medicines.